Blackstone to weigh sale of stake in HealthEdge Software
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
BLACKSTONE is exploring options for HealthEdge Software, including the sale of a stake that could value the healthcare software company at about US$3 billion, people with knowledge of the matter said.
Blackstone is working with advisers on the possible sale of a 50 per cent stake in HealthEdge, which sells software to health insurers, the people said.
It’s keen to bring in another financial investor to help it grow the business, one of the people said, asking not to not be identified discussing confidential information.
HealthEdge helps health insurers modernise their systems with software for plan design, enrolment and claims adjudication. It is projecting revenue of US$400 million next year and earnings of $60 million, one of the people said. Blackstone bought a majority stake in the Burlington, Massachusetts-based company in 2020.
Deliberations are in the early stages and there’s no certainty they’ll result in a stake sale, according to the people.
A representative for Blackstone declined to comment, while a spokesperson for HealthEdge didn’t immediately respond to a request for comment. BLOOMBERG
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Beijing’s calculated silence on the Iran war
DPM Gan warns of 3 structural shifts to the global system that will bring greater challenges – and opportunities
